JPMorgan: Raised gilead sciences' target price from $95 to $100, maintaining a "shareholding" rating.
小摩上调吉利德科学目标价至100美元
Morgan Stanley raised the target price of gilead sciences to $100.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated